PL2731584T3 - Zastosowanie związków oligosacharydowych do zapobiegania i leczenia patologicznych blizn - Google Patents

Zastosowanie związków oligosacharydowych do zapobiegania i leczenia patologicznych blizn

Info

Publication number: PL2731584T3
Authority: PL; Poland
Prior art keywords: prevention; treatment; oligosaccharide compounds; pathological scars; scars
Prior art date: 2011-07-13

Application number

PL12743514T

Other languages

English (en)

Inventor

Marielle Bouschbacher

Christelle Laurensou

Original Assignee

Urgo Recherche Innovation Et Developpement

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-07-13

Filing date

2012-07-12

Publication date

2017-05-31

2012-07-12 Application filed by Urgo Recherche Innovation Et Developpement filed Critical Urgo Recherche Innovation Et Developpement

2017-05-31 Publication of PL2731584T3 publication Critical patent/PL2731584T3/pl

Links

208000032544 Cicatrix Diseases 0.000 title 1
229920001542 oligosaccharide Polymers 0.000 title 1
-1 oligosaccharide compounds Chemical class 0.000 title 1
230000001575 pathological effect Effects 0.000 title 1
230000002265 prevention Effects 0.000 title 1
231100000241 scar Toxicity 0.000 title 1
230000037387 scars Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Birds (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Emergency Medicine (AREA)
Dermatology (AREA)
Materials Engineering (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
Toxicology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Anesthesiology (AREA)
Rheumatology (AREA)
Biochemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Saccharide Compounds (AREA)

PL12743514T 2011-07-13 2012-07-12 Zastosowanie związków oligosacharydowych do zapobiegania i leczenia patologicznych blizn PL2731584T3 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR1156436A FR2977798B1 (fr)	2011-07-13	2011-07-13	Utilisation de composes oligosaccharidiques pour la prevention et le traitement des cicatrices pathologiques
EP12743514.7A EP2731584B1 (fr)	2011-07-13	2012-07-12	Utilisation de composes oligosaccharidiques pour la prevention et le traitement des cicatrices pathologiques

Publications (1)

Publication Number	Publication Date
PL2731584T3 true PL2731584T3 (pl)	2017-05-31

Family

ID=46614546

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL12743514T PL2731584T3 (pl)	2011-07-13	2012-07-12	Zastosowanie związków oligosacharydowych do zapobiegania i leczenia patologicznych blizn

Country Status (11)

Country	Link
US (1)	US9555053B2 (pl)
EP (1)	EP2731584B1 (pl)
JP (1)	JP6087917B2 (pl)
CN (1)	CN103732209A (pl)
AU (1)	AU2012282275B2 (pl)
BR (1)	BR112014000670B1 (pl)
CA (1)	CA2839760C (pl)
ES (1)	ES2615255T3 (pl)
FR (1)	FR2977798B1 (pl)
PL (1)	PL2731584T3 (pl)
WO (1)	WO2013007960A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0605949D0 (en) *	2006-03-24	2006-05-03	Quest Int Serv Bv	Milk product for skin treatment
EP3145533B8 (en) *	2014-05-23	2024-05-01	Reponex Pharmaceuticals A/S	Compositions for promoting the healing of wounds
EP3171887A1 (en)	2014-07-24	2017-05-31	Reponex Pharmaceuticals APS	Compositions comprising granulocyte-macrophage colony-stimulating factor for the treatment of inflammatory bowel disease
CN104926889A (zh) *	2015-05-24	2015-09-23	广西师范学院	蔗糖硫酸酯铜银类化合物及其制作方法和用途
FR3043556B1 (fr) *	2015-11-17	2020-01-10	Urgo Recherche Innovation Et Developpement	Utilisation de composes oligosaccharidiques pour activer l'angiogenese

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1576522A (en)	1977-05-24	1980-10-08	Colorplast International A S	Sealing material for ostomy devices
DK147035C (da)	1980-12-05	1984-09-03	Coloplast As	Hudplade
AU607690B2 (en) *	1985-12-24	1991-03-14	Marion Laboratories, Inc.	Use of synthetic sulfated saccharides to enhance wound healing
US4912093A (en) *	1986-10-01	1990-03-27	Marion Laboratories, Inc.	Use of synthetic sulfated saccharides to enhance wound healing
US5916880A (en) *	1987-12-21	1999-06-29	Bukh Meditec A/S	Reduction of skin wrinkling using sulphated sugars
US5618798A (en) *	1989-04-20	1997-04-08	Bar-Shalom; Daniel	Use of sucralfate to treat baldness
FR2783412B1 (fr)	1998-09-18	2000-12-15	Lhd Lab Hygiene Dietetique	Compresse non adherente sterile
TR200402446T4 (tr) *	2001-05-03	2004-12-21	Farmigea S.P.A.	Servik aşınmanın tedavisi için sükralfatın kullanımı.
FR2824474B1 (fr) *	2001-05-11	2004-01-02	Fabre Pierre Dermo Cosmetique	Composition cosmetique a base de sucralfate et de sulfates de cuivre et de zinc
ITMI20012188A1 (it)	2001-10-19	2003-04-19	Interalta S R L	Sali d'argento del saccarosio - ottosolfato
DE102004034786A1 (de)	2004-07-19	2006-03-16	Patent-Treuhand-Gesellschaft für elektrische Glühlampen mbH	Glühlampe mit carbidhaltigem Leuchtkörper
FR2916355B1 (fr) *	2007-05-25	2009-08-28	Urgo Soc Par Actions Simplifie	Nouveau principe actif dans la cicatrisation et son utilisation
FR2953522B1 (fr) *	2009-12-07	2012-03-09	Fabre Pierre Dermo Cosmetique	Sucrose octasulfates de zinc, leur preparation et leurs applications pharmaceutiques et cosmetiques

2011
- 2011-07-13 FR FR1156436A patent/FR2977798B1/fr not_active Expired - Fee Related
2012
- 2012-07-12 EP EP12743514.7A patent/EP2731584B1/fr not_active Not-in-force
- 2012-07-12 JP JP2014519615A patent/JP6087917B2/ja not_active Expired - Fee Related
- 2012-07-12 AU AU2012282275A patent/AU2012282275B2/en not_active Ceased
- 2012-07-12 CA CA2839760A patent/CA2839760C/fr not_active Expired - Fee Related
- 2012-07-12 BR BR112014000670A patent/BR112014000670B1/pt not_active IP Right Cessation
- 2012-07-12 ES ES12743514.7T patent/ES2615255T3/es active Active
- 2012-07-12 CN CN201280034089.2A patent/CN103732209A/zh active Pending
- 2012-07-12 PL PL12743514T patent/PL2731584T3/pl unknown
- 2012-07-12 US US14/131,832 patent/US9555053B2/en not_active Expired - Fee Related
- 2012-07-12 WO PCT/FR2012/051668 patent/WO2013007960A1/fr not_active Ceased

Also Published As

Publication number	Publication date
AU2012282275B2 (en)	2017-03-23
CA2839760C (fr)	2020-03-24
FR2977798A1 (fr)	2013-01-18
EP2731584B1 (fr)	2017-01-11
BR112014000670B1 (pt)	2018-10-09
AU2012282275A1 (en)	2014-01-30
CA2839760A1 (fr)	2013-01-17
BR112014000670A2 (pt)	2017-01-10
US9555053B2 (en)	2017-01-31
ES2615255T3 (es)	2017-06-06
WO2013007960A1 (fr)	2013-01-17
JP2014520837A (ja)	2014-08-25
US20140141058A1 (en)	2014-05-22
EP2731584A1 (fr)	2014-05-21
CN103732209A (zh)	2014-04-16
FR2977798B1 (fr)	2016-07-29
JP6087917B2 (ja)	2017-03-01

Publication	Publication Date	Title
IL261768B (en)	2021-05-31	Devices and methods for tissue treatment
GB2524689B (en)	2016-01-27	Cannabinoids for use in the treatment of neuropathic pain
SG10201509279QA (en)	2015-12-30	Compositions and methods for the prevention and treatment of cancer
GB201115711D0 (en)	2011-10-26	Phyto-cannabinoids for use in the treatment of cancer
PT2740793T (pt)	2018-02-23	Composição de fármacos para o tratamento e/ou a prevenção de cancro
IL251083A0 (en)	2017-04-30	Compounds and preparations for the treatment of cancer
SG2014014724A (en)	2014-07-30	METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS
ZA201208646B (en)	2013-09-25	Pharmaceutical combination for the treatment of pain
ZA201408055B (en)	2016-03-30	Compositions and methods for the treatment of local pain
EP2621498A4 (en)	2014-04-09	COMBINED TREATMENT OF DERMATOLOGICAL CONDITIONS
IL225793A0 (en)	2013-09-30	Methods and preparations for curing insulin-related medical conditions
SMT201800604T1 (it)	2019-01-11	Composti per il trattamento di obesita' e metodi di uso degli stessi
PL2538918T3 (pl)	2015-05-29	Cytocholina do leczenia jaskry
IL238126B (en)	2019-07-31	Compositions for the treatment and prevention of obesity
IL235272B (en)	2018-10-31	Alfentanil preparation for the treatment of acute pain
IL275636A (en)	2020-08-31	Medical combination for cancer treatment
GB201114289D0 (en)	2011-10-05	Flurbiprofen and related compounds for the treatment of skin diseases
HUE055818T2 (hu)	2021-12-28	Eszköz bõrsérülés kezelésére
ZA201408065B (en)	2016-04-28	Compositions and methods for the treatment of diabetes
LT2460509T (lt)	2018-03-12	Kompozicija, skirta karpų gydymui
PT2456445E (pt)	2014-07-17	Agente para o tratamento de condições da pele
HK1195925A (en)	2014-11-28	Methods and compositions for the treatment and diagnosis of cancer
HK1192145A (en)	2014-08-15	Cannabinoids for use in the treatment of neuropathic pain
IL204097A0 (en)	2010-11-30	Medicine for the treatment of skin cancer
IL232294B (en)	2018-05-31	Preparations for the treatment of diabetes